about
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancerIntra-operative peritoneal lavage for colorectal cancerCytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.Analysis of high molecular mass proteins larger than 150 kDa using cyanogen bromide cleavage and conventional 2-DE.Closed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study.Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials.GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study.Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab.GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma.Natural history of peritoneal carcinomatosis from nongynecologic malignancies.Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderly.Laparoscopic total colectomy: Does the indication influence the outcome?Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.Age Nutrition Chirugie (ANC) study: impact of a geriatric intervention on the screening and management of undernutrition in elderly patients operated on for colon cancer, a stepped wedge controlled trial.Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?Childbearing after hyperthermic intraperitoneal chemotherapy: results from an international survey.The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.Natural history of peritoneal carcinomatosis from digestive origin.Impact of hyperthermic intraperitoneal chemotherapy on Hsp27 protein expression in serum of patients with peritoneal carcinomatosis.Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies.Management of peritoneal carcinomatosis from colorectal cancer: current state of practice.The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics.Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis.The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis.Intra-Thoracic Chemo-Hyperthermia for pleural recurrence of thymoma.Registries on peritoneal surface malignancies throughout the world, their use and their options.Cytoreductive Surgery and Peritonectomy Procedures.What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.Adnexal masses associated with peritoneal involvement: diagnosis with CT and MRI.The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma.18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.
P50
Q26774538-AA067FDD-DAB8-4FED-8076-1F43FB747E98Q26829874-ABE26DE1-B223-4A38-A98E-02EE81EE60CDQ33262026-9823496F-3FF9-43D6-8189-CCDFA8F1A8ADQ33377087-9547BF2A-9CD6-4606-A901-1D9E1253AFD4Q33394590-67189764-3776-49A8-BB92-7E700B6BC7CAQ34276733-74CF12B9-A598-42FD-89B6-A56996037D36Q34658004-278BAE6E-328E-4CD8-BEF3-A92A34615BDCQ35083070-F903E5F1-6C41-4D5C-89C8-B70E41684AACQ35109585-9C11B303-F402-405E-B7C3-AA9973FF606CQ35120716-0F400512-E088-4F57-BDA5-4EB5B3ADDC30Q35563249-CB41B51E-C488-4646-A482-A32F098DFE90Q35563265-4948F5C8-1F47-4108-AF33-FED48E097D48Q35579738-DC2691D2-FCF1-4470-8926-BDF317E715C4Q35618819-40BC7E00-3065-41DA-8845-A632607F6127Q36021874-7A12230C-DF6C-4BCF-A896-C7749130ED4CQ36243265-81068FF4-0B75-4875-B6AF-1B88275F27E1Q36289514-B5DE8981-BEFA-42E1-89EC-8BA11F9568A2Q36418070-4E0D1AFA-A415-4B71-9698-8D04D8083635Q36758921-C5F11FF0-3621-4E35-A101-7987B9E94116Q36758929-C87B26C3-09AB-4541-BF9A-A08F7F616EC1Q36882738-28378D8F-1CA8-44B3-BDDE-32E243B33BF3Q37099476-E88F3946-6079-4F65-8F6C-0007A5AAE86EQ37340522-CCF34B35-455A-477C-829C-EFE1ED6D281EQ37531814-B4B5C897-C673-44EB-B05D-CB868D0DE0F7Q37650823-D50E7EB8-488B-425C-A334-137DA3D7E70DQ37987561-6F28F792-EC8E-4401-B4B5-E4D38A99DBFDQ38199370-135F965F-6BFE-4509-9C81-8473618EBD27Q38214032-6EBC586D-3161-4505-B28F-A5EC9E97DD04Q38244330-7809C3BB-1CD2-4413-8304-92CFC1D16477Q38456068-62202C21-2F36-412A-9697-1CB536B7B110Q38720464-47BF88B6-C771-4287-ADA9-EF25367EFFD2Q38765792-ED4C29E5-ED3F-471A-A3DE-207F76B6E37DQ38804694-98899D8B-2C97-4DC5-A093-4695E370A667Q38816501-3297D1DD-6313-4961-B540-A4BC45B34563Q38822632-7A8C84AA-CFA6-4C39-B053-8FC85DD57DA2Q38829910-BB07CD03-A3FC-4460-8766-9E67BF523EECQ38896167-09CD9531-461A-4F6B-9DED-1799C2C7944EQ38937425-1DCBCB93-A7E2-40DE-BBF8-F9FE255DD3D6Q39001937-3024CCE7-FFED-4534-91DA-FA9B2AC72B92Q39051937-F09BD75D-847C-44E1-BB1B-BC94777671C7
P50
description
researcher ORCID ID = 0000-0002-2802-4974
@en
wetenschapper
@nl
name
Olivier Glehen
@ast
Olivier Glehen
@en
Olivier Glehen
@es
Olivier Glehen
@nl
type
label
Olivier Glehen
@ast
Olivier Glehen
@en
Olivier Glehen
@es
Olivier Glehen
@nl
prefLabel
Olivier Glehen
@ast
Olivier Glehen
@en
Olivier Glehen
@es
Olivier Glehen
@nl
P214
P106
P214
P31
P496
0000-0002-2802-4974
P735
P7859
lccn-n2014182439